Pharmacokinetics, Pharmacodynamics and Safety of Belimumab in Chinese Patients with Systemic Lupus Erythematosus: A Phase I, Open-Label StudyJing Zhang, Peiming Ma, Liyan Miao et al.|Rheumatology and Therapy|2020Cited by 7